InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,731.69
(
-0.25%
)
Post# of 39
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Teamlasvegas

Send PM Follow Ignore
Followers 31
Posts 6662
Boards Moderated 0
Alias Born 11/24/2002

Teamlasvegas

Re: None

Friday, 12/28/2007 12:52:56 PM

Friday, December 28, 2007 12:52:56 PM

Post# of 39
Shares of Immtech Pharmaceuticals Inc. (IMM) were on the rebound, up 10% to $2.38. The stock lost almost half its value earlier in the week after Immtech said it was temporarily halting Phase III testing of its drug parfuramidine over safety concerns. The company has been testing the drug against a certain type of pneumonia that commonly strikes AIDS patients.
Immtech has been co-developing parfuramidine with Par Pharmaceutical Cos. (PRX). Shares of Par were down almost 3% to $23.72.

"Your Vegas Is Showing"
I've been to Hollywood
I've been to Redwood
I crossed the ocean
for a heart of gold
I've been in my mind,
it's such a fine line
Later, The Team.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up